India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:500040 has a market cap or net worth of INR 208.47 billion. The enterprise value is 245.31 billion.
| Market Cap | 208.47B |
| Enterprise Value | 245.31B |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Jul 15, 2025 |
Share Statistics
BOM:500040 has 111.71 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Current Share Class | 111.71M |
| Shares Outstanding | 111.71M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | +3.71% |
| Owned by Insiders (%) | 1.90% |
| Owned by Institutions (%) | 28.68% |
| Float | 59.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5,561.04 |
| PS Ratio | 20.43 |
| PB Ratio | 5.36 |
| P/TBV Ratio | 5.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -126.10 |
| EV / Sales | 24.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.88% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.23M |
| Profits Per Employee | -806,844 |
| Employee Count | 2,411 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -485.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.50% in the last 52 weeks. The beta is 0.42, so BOM:500040's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -10.50% |
| 50-Day Moving Average | 2,216.75 |
| 200-Day Moving Average | 2,230.84 |
| Relative Strength Index (RSI) | 25.05 |
| Average Volume (20 Days) | 5,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500040 had revenue of INR 10.21 billion and -1.95 billion in losses. Loss per share was -17.62.
| Revenue | 10.21B |
| Gross Profit | 4.05B |
| Operating Income | -1.10B |
| Pretax Income | -2.55B |
| Net Income | -1.95B |
| EBITDA | -813.95M |
| EBIT | -1.10B |
| Loss Per Share | -17.62 |
Balance Sheet
The company has 13.61 billion in cash and 49.97 billion in debt, giving a net cash position of -36.36 billion or -325.47 per share.
| Cash & Cash Equivalents | 13.61B |
| Total Debt | 49.97B |
| Net Cash | -36.36B |
| Net Cash Per Share | -325.47 |
| Equity (Book Value) | 38.88B |
| Book Value Per Share | 343.77 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.66%, with operating and profit margins of -10.73% and -19.06%.
| Gross Margin | 39.66% |
| Operating Margin | -10.73% |
| Pretax Margin | -24.94% |
| Profit Margin | -19.06% |
| EBITDA Margin | -7.98% |
| EBIT Margin | -10.73% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 0.62% |
| Earnings Yield | -0.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |